{
    "nctId": "NCT03580109",
    "briefTitle": "Spa Therapy for Upper or Lower Limb Lymphoedema",
    "officialTitle": "Spa Therapy for Upper or Lower Limb Lymphoedema : a Randomized and Comparative Study",
    "overallStatus": "RECRUITING",
    "conditions": "Lymphoedema, Breast Cancer, Malignant Disease, Gynaecological Cancer, Lymphoma, Prostate Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 160,
    "primaryOutcomeMeasure": "Evolution of lymphoedema quality of life assessed by the rate of patient with an improvement of the LMS27 scale (for upper limb lymphoedema).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years old and older\n* available for a spa treatment (phlebology indication) during 18 days and a follow up period of 15 months\n* with permanent lymphoedema of the upper or lower limb (2 ou 3 stade of International Society for Lymphology scale)\n* voluntary to participate to the study, informed consent form signed after appropriate information\n* affiliation to the social security system or equivalent\n\nExclusion Criteria:\n\n* cancer undergoing chemotherapy and radiotherapy treatment in primary phase\n* the baseline score of LMS27 or LYMQOL-LEG \\> 79\n* pain of upper limb linked with a radical plexitis\n* contra-indication of spa treatment (cancer in progress, psychiatrics disorders, immunodeficiency)\n* Erysipelas case history in the last 6 months or pachyderma and lymphangiectasia\n* no previous spa treatment for upper limb lymphoedema during the spa year\n* risk of intensive treatment in the next 6 months\n* subject participating to an other clinical study interventional\n* pregnancy, parturient or breast feeding",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}